J.P. Morgan Maintains UnitedHealth(UNH.US) With Buy Rating, Announces Target Price $525
UnitedHealth Is Maintained at Overweight by JP Morgan
UnitedHealth Price Target Cut to $525.00/Share From $652.00 by JP Morgan
Barclays Maintains UnitedHealth(UNH.US) With Buy Rating, Cuts Target Price to $513
Barclays Reaffirms Their Buy Rating on UnitedHealth (UNH)
RBC Capital Maintains UnitedHealth(UNH.US) With Buy Rating, Cuts Target Price to $525
RBC Capital Maintains Outperform on UnitedHealth Group, Lowers Price Target to $525
UnitedHealth Group Analyst Ratings
Barclays Adjusts Price Target on UnitedHealth Group to $513 From $560, Maintains Overweight Rating
Bernstein Maintains UnitedHealth(UNH.US) With Buy Rating, Cuts Target Price to $594
Morgan Stanley Maintains UnitedHealth(UNH.US) With Buy Rating, Cuts Target Price to $563
UnitedHealth Group Analyst Ratings
UnitedHealth Price Target Cut to $563.00/Share From $664.00 by Morgan Stanley
Morgan Stanley Maintains Overweight on UnitedHealth Group, Lowers Price Target to $563
A Quick Look at Today's Ratings for UnitedHealth(UNH.US), With a Forecast Between $490 to $600
HSBC Downgrades UnitedHealth Group to Hold From Buy, Adjusts Price Target to $490 From $600
Analysts Offer Insights on Healthcare Companies: UniQure (QURE) and UnitedHealth (UNH)
Jefferies Adjusts Price Target on UnitedHealth Group to $530 From $609
UnitedHealth Is Maintained at Overweight by Keybanc
Barclays Maintains Overweight on UnitedHealth Group, Lowers Price Target to $560